HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Development of a Microsimulation Model to Predict Stroke and Long-Term Mortality in Adherent and Nonadherent Medically Managed and Surgically Treated Octogenarians with Asymptomatic Significant Carotid Artery Stenosis.

AbstractBACKGROUND:
The primary study objective was to develop a microsimulation model to predict preventable first-ever and recurrent strokes and mortality for a population of medically or surgically managed octogenarians with substantial (>60%) asymptomatic carotid artery stenosis and comparing an adherent with a real-world nonadherent best medical treatment (BMT) regimen subjected to sex.
METHODS:
A Monte Carlo microsimulation model was constructed with a 14-year time horizon and with 10,000 patients. Probabilities and values for clinical outcomes were obtained from the current literature.
RESULTS:
The stratification of the microsimulation estimates by treatment strategy within the female group of octogenarians showed a statistically significant lower stroke rate during follow-up for carotid endarterectomy (CEA) compared with nonadherent BMT (P < 0.0001) as well as compared with adherent BMT (P < 0.0001). In male octogenarians, the CEA strategy was also associated with statistically significant lower stroke rates compared with adherent and nonadherent BMT (P < 0.0001 and P < 0.0001, respectively). For each treatment strategy, female octogenarians had a statistically significant longer overall long-term survival compared with male octogenarians (P < 0.0001, respectively). In terms of stratification by sex, in octogenarian men and women, long-term survival was significantly better for adherent BMT compared with nonadherent BMT, and CEA was associated with a significant better long-term survival compared with nonadherent BMT.
CONCLUSIONS:
In the present microsimulation, in real-world drug adherence, it was likely that a strategy of early endarterectomy was beneficial in octogenarians with significant asymptomatic carotid artery disease compared with BMT alone.
AuthorsThomas Luebke, Jan Brunkwall
JournalWorld neurosurgery (World Neurosurg) Vol. 92 Pg. 513-520.e2 (Aug 2016) ISSN: 1878-8769 [Electronic] United States
PMID27237419 (Publication Type: Journal Article)
CopyrightCopyright © 2016 Elsevier Inc. All rights reserved.
Chemical References
  • Fibrinolytic Agents
Topics
  • Aged
  • Aged, 80 and over
  • Asymptomatic Diseases (mortality)
  • Carotid Stenosis (mortality, therapy)
  • Combined Modality Therapy (mortality, statistics & numerical data)
  • Computer Simulation
  • Endarterectomy, Carotid (mortality)
  • Female
  • Fibrinolytic Agents (therapeutic use)
  • Geriatric Assessment (statistics & numerical data)
  • Humans
  • Longitudinal Studies
  • Male
  • Medication Adherence (statistics & numerical data)
  • Postoperative Complications (mortality, prevention & control)
  • Prognosis
  • Proportional Hazards Models
  • Reproducibility of Results
  • Risk Assessment (methods)
  • Stroke (mortality)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: